LDS/Medical Tests/TERC Gene Mutation Analysis

TERC Gene Mutation Analysis

Telomeres are found at the ends of chromosomes and are composed of TTAGGG nucleotide repeats and proteins that protect the chromosome from deterioration or fusion with other chromosomes. During cell division telomeres become truncated and if sufficiently truncated may result in replicative senescence of the cell. Telomerase is an enzyme complex that can extend the length of the telomeres, thus helping to slow the shortening process. Telomerase is most active in highly proliferative tissues such as lymphocytes, skin, intestine, and bone marrow as well as in certain cancers.

Mutations in genes involved with telomere repair and maintenance may cause telomeres to shorten more quickly than normal resulting in early cell senescence. The TERC gene is located on the long (q) arm of chromosome 3 at position 26.2 and encodes the RNA component of telomerase that acts as a template for the telomere repeat. Mutations in TERC are associated with dyskeratosis congenita, idiopathic pulmonary fibrosis, and aplastic anemia.

Dyskeratosis congenita is characterized by a classic triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia. Other findings can include abnormal pigmentation changes not restricted to the upper chest and neck, eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), and dental abnormalities (caries, periodontal disease, taurodauntism). Individuals with dyskeratosis congenita are also at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome (MDS), acute myelogenous leukemia (AML), solid tumors and pulmonary fibrosis. Most of the TERC gene mutations that cause dyskeratosis congenita are missense mutations and result in an unstable or dysfunctional TERC. The defective protein interferes with telomerase function, leading to impaired maintenance of telomeres and reduced telomere length. As a result, people with dyskeratosis congenita may experience a variety of problems affecting quickly dividing cells in the body such as cells of the nail beds, hair follicles, skin, lining of the GI tract and bone marrow. Truncated telomeres also increase chromosome instability and breakage which may lead to the development of cancer.

Idiopathic pulmonary fibrosis is the term given to a group of disorders characterized by relentless fibrosis of the lower respiratory tract. Mutations in TERC gene have been associated with 8%-15% of families with idiopathic pulmonary fibrosis (IPF), and germline mutations in TERC are seen in 1%-3% of simplex cases of idiopathic pulmonary fibrosis (IPF). IPF typically presents in middle to older aged adults and causes shortness of breath and a chronic non-productive cough. Fatigue at rest, fever, myalgias and arthralgias are rarely reported.

  • For the confirmation of a clinical diagnosis of TERC-associated dyskeratosis congenital, Idiopathic pulmonary fibrosis and some cancers
  • For the carrier testing for family members of the affected patient
  • For the confirmation that a potential hematopoietic stem cell transplant donor is not affected
  • For the prenatal diagnosis in at-risk pregnancies

Positive: Mutation or pathogenic variant in TERC gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative: No mutation or pathogenic variant in TERC gene.

Negative for mutation or pathogenic variant in TERC gene

Sequence analysis by next generation sequencing or bi-directional sequencing. SMAD2 gene -targeted deletion/duplication analysis by quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.

Whole blood (EDTA), Skin biopsy.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Telomere Defects Gene Panel, pathogenic variants analysis in ACD, PARN, CTC1, DKC1, NHP2, NOP10, RTEL1, TERT, TINF2, USB1 (C16ORF57), and WRAP53 (TCAB1) genes, bone marrow biopsy, multicolor flow cytometry, fluorescence in situ hybridization (flow-FISH).
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login